VanEck Vectors Biotech ETF (BBH)

Add to Watchlists
Create an Alert
126.78 +1.26  +1.00% NASDAQ Aug 19, 20:00 Delayed 2m USD
View Full Chart
Price Chart

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 1.67% 1.49% -1.94% 5
3M 5.61% 5.48% 2.00% 32
6M -1.30% -1.35% -2.09% 64
YTD 14.51% 13.82% 10.33% 31
1Y -1.53% -1.54% -3.17% 57
3Y 3.69% 3.67% 8.44% 85
5Y 4.53% 4.52% 8.30% 83
10Y -- -- 14.69% --
15Y -- -- 11.00% --
20Y -- -- 10.08% --
As of Aug. 19, 2019. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash -0.05% 0.00% 0.05%
Stock 100.0% 100.0% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Aug. 19, 2019

Region Exposure

Americas 92.90%
North America 92.90%
Latin America 0.00%
Greater Europe 2.66%
United Kingdom 0.00%
Europe Developed 2.66%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 4.44%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 4.44%
Market Classification
% Developed Markets 95.56%
% Emerging Markets 4.44%
As of Aug. 19, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Aug. 19, 2019

Stock Market Capitalization

Giant 10.84%
Large 55.47%
Medium 32.47%
Small 1.21%
Micro 0.00%
As of Aug. 19, 2019

Stock Style Exposure

Large Cap Value 30.79%
Large Cap Blend 15.78%
Large Cap Growth 18.14%
Mid Cap Value 0.00%
Mid Cap Blend 0.00%
Mid Cap Growth 34.02%
Small Cap Value 0.00%
Small Cap Blend 1.27%
Small Cap Growth 0.00%
As of Aug. 19, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
AMGN Amgen Inc 10.85% 203.03 -1.44%
GILD Gilead Sciences Inc 7.43% 63.52 -0.92%
CELG Celgene Corp 6.85% 95.40 +0.19%
AGN Allergan PLC 6.23% 159.38 +0.08%
IQV IQVIA Holdings Inc 5.36% 155.01 -1.09%
VRTX Vertex Pharmaceuticals Inc 5.25% 183.04 -2.16%
BIIB Biogen Inc 4.90% 230.97 -2.02%
INCY Incyte Corp 4.80% 84.14 -0.45%
BGNE BeiGene Ltd ADR 4.55% 146.16 -1.44%
EXAS Exact Sciences Corp 4.53% 119.94 +1.51%
As of Aug. 19, 2019
Advertisement

One Page Reports

Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Unaligned
Fund Owner Firm Name VanEck
Benchmark Index
MVIS US Listed Biotech 25 NR USD
100.0%

Manager Info

Name Tenure
Guo Hua (Jason) Jin 1.33 yrs
Hao-Hung (Peter) Liao 7.45 yrs

Net Fund Flows

1M -6.350M
3M -36.72M
6M -56.01M
YTD -61.95M
1Y -91.96M
3Y -287.91M
5Y -259.45M
10Y --
As of July 31, 2019

Risk Info

Beta (5Y) 1.352
Max Drawdown (All) 33.76%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 1.32
30-Day Rolling Volatility 17.38%
Daily Value at Risk (VaR) 1% (All) 3.76%
Monthly Value at Risk (VaR) 1% (All) 15.02%

Fundamentals

Dividend Yield TTM (8-19-19) 0.43%
30-Day SEC Yield (10-30-15) 0.24%
7-Day SEC Yield --
Weighted Average PE Ratio 18.59
Weighted Average Price to Sales Ratio 5.504
Weighted Average Price to Book Ratio 3.950
Weighted Median ROE 18.42%
Weighted Median ROA 4.64%
Forecasted Dividend Yield 0.85%
Forecasted PE Ratio 14.28
Forecasted Price to Sales Ratio 4.902
Forecasted Price to Book Ratio 3.381
Number of Holdings 27
As of Aug. 19, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 10.58%
Forecasted Book Value Growth 7.42%
Forecasted Cash Flow Growth 6.60%
Forecasted Earnings Growth 18.70%
Forecasted Revenue Growth 8.78%
As of Aug. 19, 2019

Comparables

Edit

Attributes

Key Dates
Inception Date 12/20/2011
Termination Date
Last Annual Report Date 9/30/2018
Last Prospectus Date 2/1/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

Excel Add-In Codes

  • Name: =YCI("BBH","name")
  • Broad Asset Class: =YCI("BBH", "broad_asset_class")
  • Broad Category: =YCI("BBH", "broad_category_group")
  • Prospectus Objective: =YCI("BBH", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.